Stifel Financial
AVXL icon

Stifel Financial’s Anavex Life Sciences AVXL Stock Holding History

Stifel Financial’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$861K Buy
332,597
+95,793
+40% +$283K ﹤0.01% 2650
2026
Q1 		$727K Buy
236,804
+135,784
+134% +$588K ﹤0.01% 2644
2025
Q4 		$360K Buy
101,020
+49,229
+95% +$302K ﹤0.01% 3044
2025
Q3 		$461K Buy
51,791
+3,700
+8% +$37.5K ﹤0.01% 2869
2025
Q2 		$443K Buy
48,091
+2,494
+5% +$21.3K ﹤0.01% 2845
2025
Q1 		$391K Buy
+45,597
New +$431K ﹤0.01% 2840

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Stifel Financial's AVXL Position: Q2 2026 in Review

Stifel Financial increased its Anavex Life Sciences (AVXL) stake by 40% in Q2 2026, buying an estimated $283K and bringing the position to 332,597 shares worth $861K. The position accounts for ﹤0.01% of the portfolio, ranked #2650.

Stifel Financial first reported a position in AVXL in Q1 2025 and has held it in 6 quarters since. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Stifel Financial held 332,597 shares of Anavex Life Sciences worth $861K as of Q2 2026.
  • Stifel Financial bought 95,793 Anavex Life Sciences shares in Q2 2026, an estimated $283K.
  • Anavex Life Sciences made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2650 holding.
  • Stifel Financial first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.